ⓘ Sutimlimab

                                     

ⓘ Sutimlimab

Sutimlimab is a monoclonal antibody that is being investigated for cold agglutinin disease.

This drug is developed Bioverativ, and the company "Sanofi". In 2018, sutimlimab undergoing phase III clinical trials.

Sutimlimab prevents complement activation, elevated autoimmune human cells in vitro.